New Delhi: India on Thursday reiterated that Bangladesh will get high priority in supply of Covid vaccine, once it gets ready.
During foreign secretary Harsh Vardhan Shringla’s visit to Bangladesh, the issue was discussed.
“As a close neighbour and strategic partner, we have assured the Bangladesh side that Bangladesh will get high priority in supply of vaccine, once ready. We are glad to note that enterprises on both sides are also taking steps towards this end,” Ministry of External Affairs spokesperson Anurag Shrivastava said in his virtual weekly press briefing here on Thursday.
Days after Harsh Vardhan Shringla's visit to Dhaka, Bangladesh's largest pharma company Beximco Pharmaceuticals announced that it is investing in the Serum Institute of India for the vaccine.
Issuing a statement, the company said, “Once the vaccine receives regulatory approvals, SII will include Bangladesh among the countries who will be the first to receive an agreed quantity” of the Covid vaccine.
India currently produces over 60 per cent of the world's vaccine and amidst the Covid pandemic supplied hydroxychloroquine and paracetamol to over 100 countries.
